Evidence map›Paper›PMID 38441007›Full record

ReviewCurrent cardiology reviews2024

Cross Talks between CNS and CVS Diseases: An Alliance to Annihilate.

Shivani Chib, Sushma Devi, Rishabh Chalotra, Neeraj Mittal, Thakur Gurjeet Singh, Puneet Kumar, Randhir Singh

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in Current cardiology reviews, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Shivani ChibDepartment of Pharmacology, Central University of Punjab, Bathinda, Punjab, India.
Sushma DeviDepartment of Pharmacology, Chitkara College of Pharmacy, Chitkara University, Punjab, India.
Rishabh ChalotraDepartment of Pharmacology, Central University of Punjab, Bathinda, Punjab, India.
Neeraj MittalDepartment of Pharmacology, Central University of Punjab, Bathinda, Punjab, India.
Thakur Gurjeet SinghDepartment of Pharmacology, Central University of Punjab, Bathinda, Punjab, India.
Puneet KumarDepartment of Pharmacology, Chitkara College of Pharmacy, Chitkara University, Punjab, India.
Randhir SinghDepartment of Pharmacology, Central University of Punjab, Bathinda, Punjab, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cardiovascular and neurological diseases cause substantial morbidity and mortality globally. Moreover, cardiovascular diseases are the leading cause of death globally. About 17.9 million people are affected by cardiovascular diseases and 6.8 million people die every year due to neurological diseases. The common neurologic manifestations of cardiovascular illness include stroke syndrome which is responsible for unconsciousness and several other morbidities significantly diminished the quality of life of patients. Therefore, it is prudent need to explore the mechanistic and molecular connection between cardiovascular disorders and neurological disorders. The present review emphasizes the association between cardiovascular and neurological diseases specifically Parkinson's disease, Alzheimer's disease, and Huntington's disease.

Indexed as

Cerebrovascular DisordersCardiovascular DiseasesCentral Nervous System DiseasesHumansQuality of LifeAlzheimer’s diseaseCardiovascular disordersHuntington’s diseaseneurological disordersoxidative stress.Parkinson’s disease

Identifiers

PMID38441007
PMCPMC11284694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.